Deborah Allen Selected Research

Deborah Allen Research Topics

12	Neoplasms (Cancer) 01/2020 - 11/2005
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 11/2005
2	Circulating Neoplastic Cells 07/2016 - 03/2012
2	Triple Negative Breast Neoplasms 01/2016 - 03/2012
2	Lymphoma (Lymphomas) 03/2012 - 05/2011
2	Glioma (Gliomas) 04/2004 - 04/2004
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Hemorrhage 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Disease Progression 01/2016
1	Alveolar Soft Part Sarcoma 06/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2012
1	Ovarian Neoplasms (Ovarian Cancer) 03/2012
1	Neoplasm Metastasis (Metastasis) 08/2011
1	Hypoxia (Hypoxemia) 08/2011
1	Fatigue 05/2011
1	Chronic Disease (Chronic Diseases) 07/2010
1	Prostatic Neoplasms (Prostate Cancer) 11/2005
1	Colorectal Neoplasms (Colorectal Cancer) 11/2005
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2005
1	Virus Diseases (Viral Diseases) 11/2002

2	Alkylating AgentsIBA 01/2020 - 03/2012
2	Bevacizumab (Avastin)FDA Link 01/2020 - 05/2011
2	veliparibIBA 01/2016 - 03/2012
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2016 - 03/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 03/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 04/2004 - 04/2004
2	Carmustine (FIVB)FDA Link 04/2004 - 04/2004
1	AntiemeticsIBA 01/2019
1	Dronabinol (THC)FDA LinkGeneric 01/2019
1	RadonIBA 12/2016
1	Histones (Histone)IBA 07/2016
1	NSC 724998IBA 07/2016
1	Aromatase InhibitorsIBA 01/2016
1	Tamoxifen FDA LinkGeneric 01/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016
1	cediranib (AZD2171)IBA 06/2013
1	ropidoxuridine (IPdR)IBA 04/2013
1	ProdrugsIBA 04/2013
1	Poly Adenosine Diphosphate RiboseIBA 03/2012
1	Topotecan (Hycamtin)FDA LinkGeneric 08/2011
1	Hypoxia-Inducible Factor 1IBA 08/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2011
1	Epidermal Growth Factor (EGF)IBA 05/2011
1	vandetanib (ZD6474)IBA 05/2011
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2011
1	Flutamide (Eulexin)FDA LinkGeneric 11/2005
1	Tyrosine Kinase InhibitorsIBA 11/2005
1	Gefitinib (Iressa)FDA Link 11/2005
1	ErbB Receptors (EGF Receptor)IBA 11/2005
1	Topoisomerase I InhibitorsIBA 04/2004
1	Interferon Type IIBA 11/2002

5	Drug Therapy (Chemotherapy) 01/2021 - 11/2005
5	Therapeutics 01/2020 - 11/2005
2	Aftercare (After-Treatment) 01/2020 - 08/2011
1	Extracorporeal Membrane Oxygenation 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Hospital to Home Transition 01/2019
1	Transitional Care 01/2019
1	Length of Stay 01/2017
1	Palliative Care (Palliative Therapy) 01/2017
1	Duration of Therapy 01/2016
1	Oral Administration 03/2012